Our tests showed that RBBP4 knockdown resulted in increased levels of LC3‐II and Beclin‐1, along with a reduction in P62 levels, thereby confirming RBBP4's role in inhibiting autophagy in NSCLC. The gene discussed is RBBP4; the disease is non-small cell lung carcinoma.